OliX Pharmaceuticals Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for Age-related Macular Degeneration
SUWON, South Korea--(BUSINESS WIRE)-- #AgeRelatedMacularDegeneration--FDA has approved the OliX Pharmaceuticals' Investigational New Drug application to develop OLX10212 for age-related macular degeneration.